These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22727796)

  • 1. Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade.
    Sasser JM; Moningka NC; Tsarova T; Baylis C
    Life Sci; 2012 Jul; 91(1-2):54-63. PubMed ID: 22727796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade.
    Moningka NC; Tsarova T; Sasser JM; Baylis C
    Nephrol Dial Transplant; 2012 Mar; 27(3):913-20. PubMed ID: 21856762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.
    Ceron CS; Rizzi E; Guimarães DA; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2013 Dec; 65():47-56. PubMed ID: 23806385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.
    Whaley-Connell A; Habibi J; Johnson M; Tilmon R; Rehmer N; Rehmer J; Wiedmeyer C; Ferrario CM; Sowers JR
    Am J Nephrol; 2009; 30(4):354-60. PubMed ID: 19609077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats.
    Habibi J; Hayden MR; Sowers JR; Pulakat L; Tilmon RD; Manrique C; Lastra G; Demarco VG; Whaley-Connell A
    Endocrinology; 2011 Feb; 152(2):659-68. PubMed ID: 21177830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol attenuates maladaptive proximal tubule remodeling in transgenic rats.
    Hayden MR; Habibi J; Whaley-Connell A; Sowers D; Johnson M; Tilmon R; Jain D; Ferrario C; Sowers JR
    Am J Nephrol; 2010; 31(3):262-72. PubMed ID: 20110666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
    Fan YY; Baba R; Nagai Y; Miyatake A; Hosomi N; Kimura S; Sun GP; Kohno M; Fujita M; Abe Y; Nishiyama A
    Hypertens Res; 2006 Mar; 29(3):169-78. PubMed ID: 16755152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olmesartan improves endothelin-induced hypertension and oxidative stress in rats.
    Yao L; Kobori H; Rahman M; Seth DM; Shokoji T; Fan Y; Zhang GX; Kimura S; Abe Y; Nishiyama A
    Hypertens Res; 2004 Jul; 27(7):493-500. PubMed ID: 15302986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol ameliorates nitric oxide deficient hypertension.
    Fortepiani LA; Ortíz MC; Atucha NM; García-Estañ J
    ScientificWorldJournal; 2002 Jun; 2():1676-84. PubMed ID: 12806161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol.
    Varagic J; Ahmad S; Brosnihan KB; Habibi J; Tilmon RD; Sowers JR; Ferrario CM
    Am J Nephrol; 2010; 32(6):557-66. PubMed ID: 21042014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release.
    Kamp O; Metra M; Bugatti S; Bettari L; Dei Cas A; Petrini N; Dei Cas L
    Drugs; 2010; 70(1):41-56. PubMed ID: 20030424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade.
    Cosentino F; Bonetti S; Rehorik R; Eto M; Werner-Felmayer G; Volpe M; Lüscher TF
    J Hypertens; 2002 Mar; 20(3):421-8. PubMed ID: 11875309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension.
    Sander GE; Giles TD
    Expert Opin Pharmacother; 2015 Apr; 16(5):763-70. PubMed ID: 25747524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebivolol improves insulin sensitivity in the TGR(Ren2)27 rat.
    Manrique C; Lastra G; Habibi J; Pulakat L; Schneider R; Durante W; Tilmon R; Rehmer J; Hayden MR; Ferrario CM; Whaley-Connell A; Sowers JR
    Metabolism; 2011 Dec; 60(12):1757-66. PubMed ID: 21640361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebivolol induces distinct changes in profibrosis microRNA expression compared with atenolol, in salt-sensitive hypertensive rats.
    Ye H; Ling S; Castillo AC; Thomas B; Long B; Qian J; Perez-Polo JR; Ye Y; Chen X; Birnbaum Y
    Hypertension; 2013 May; 61(5):1008-13. PubMed ID: 23460283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function.
    Greven J; Gabriëls G
    Arzneimittelforschung; 2000 Nov; 50(11):973-9. PubMed ID: 11148863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat.
    Ma L; Gul R; Habibi J; Yang M; Pulakat L; Whaley-Connell A; Ferrario CM; Sowers JR
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(11):H2341-51. PubMed ID: 22447938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes.
    Mizuno M; Sada T; Kato M; Koike H
    Hypertens Res; 2002 Mar; 25(2):271-8. PubMed ID: 12047043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose nitrate therapy recovers the expression of subtypes α
    Peng Y; Li Y; Chen M; Song J; Jiang Z; Shi S
    BMC Cardiovasc Disord; 2020 Feb; 20(1):99. PubMed ID: 32106816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
    Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
    Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.